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Background: With hybrid coronary revascularization (HCR), minimally-invasive CABG with left internal mammary artery (LIMA) to left anterior 
descending coronary artery (LAD) grafting is combined with percutaneous coronary intervention (PCI) of non-LAD vessels. The purpose of this study 
was to examine the short-term clinical and angiographic results in one of the largest HCR series to date.
methods: From 2003-2012, 300 consecutive patients (age=64±12, females 31%, number of diseased vessels=3.4±0.6, STS predicted risk of 
mortality 1.6±2.1%), underwent HCR procedures on an intent-to-treat basis at a single institution. After robotic or thoracoscopic LIMA harvest and 
pericardiotomy, off-pump, LIMA-LAD grafting was performed via a 3-4 cm sternal-sparing, non-rib-spreading thoracotomy. PCI was utilized to treat 
non-LAD lesions either before, after, or concomitant with the surgical procedure.
results: Of the 300 patients undergoing planned HCR, 10 (3.3%) underwent conversion to sternotomy for multivessel CABG. In the remaining 
290 patients, HCR was performed with surgery first in 228 (78.6%), PCI first in 43 (14.8%) and as a concomitant procedure in 19 (6.6%). For all 
300 patients, 30-day mortality, stroke, and non-fatal myocardial infarction occurred in 4 (1.3%), 1 (0.3%), and 6 (2.0%) patients, respectively. 
Angiographic LIMA evaluation was obtained in 265 patients which revealed a FitzGibbon A LIMA-LAD patency rate of 97.0% (257/265 patients). 
Repeat revascularization was required in 10 (3.3%) patients. For the 8 patients with FitzGibbon B or O LIMA-LAD patency, 7 underwent PCI and 1 
underwent redo-CABG. In 2 patients, non-fatal stent thrombosis occurred after PCI which was treated with PCI. 
conclusions: Hybrid coronary revascularization represents an alternative approach for patients with multivessel coronary disease with excellent 
short-term angiographic and clinical outcomes. HCR provides a minimally-invasive alternative to traditional CABG and may provide a more durable 
alternative to multivessel PCI. 
